Nitrovasodilators as a new class of ocular hypotensive agents

JA Nathanson

Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston.

Because of recent evidence indicating that hormone regulation of particulate guanylate cyclase in the eye may modulate aqueous humor dynamics, we have investigated the possibility that exogenous activators of soluble guanylate cyclase may be useful in altering intraocular pressure (IOP). A variety of nitrovasodilators known to activate guanylate cyclase were evaluated for their topical effects on IOP, outflow resistance and systemic cardiovascular parameters. In both young and older rabbits, topically applied nitroglycerin (0.003-0.1 g %) rapidly lowered IOP in a dose-dependent fashion, with a peak effect at 1 to 2 hr. Topically applied 0.1% isosorbide dinitrate, sodium nitrite, hydralazine, minoxidil and sodium nitroprusside mimicked the ocular hypotensive actions of nitroglycerin. Ipsilateral effects on IOP were greater than contralateral effects and, at the doses applied, there was little or no alteration in heart rate or systemic blood pressure, or signs of ocular irritation. Higher doses (0.5-2.0 g %) of nitroglycerin, hydralazine and sodium nitroprusside were less effective in lowering IOP. Topically applied molsidomine (0.1%), a prodrug which requires hepatic metabolism to 3-morpholino-sydnonimin hydrochloride for guanylate cyclase stimulatory activity, was ineffective in lowering IOP, whereas topical 0.1% 3-morpholino-sydnonimin hydrochloride was effective. After chronic administration, rabbits receiving nitroglycerin showed diminished ocular response, whereas repeated doses of hydralazine (56 days) did not elicit tolerance. Tonographic studies showed that topically applied nitroglycerin and hydralazine increased the facility (decreased the resistance) of aqueous humor leaving the eye. These data indicate that topically applied nitrovasodilators can effectively lower IOP at doses which have little effect on systemic blood pressure. Because these IOP-lowering effects appear to result, to a significant degree, from local actions on the eye, further investigation of these agents in conditions of elevated intraocular pressure may be warranted.

Volume 260, Issue 3, pp. 956-965, 03/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				W. M. Dismuke, C. C. Mbadugha, and D. Z. Ellis NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1378 - C1386. [Abstract] [Full Text] [PDF]

				A W Siu, G G Ortiz, G Benitez-King, C H To, and R J Reiter Effects of melatonin on the nitric oxide treated retina Br. J. Ophthalmol., August 1, 2004; 88(8): 1078 - 1081. [Abstract] [Full Text] [PDF]

				N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF]

				D. Z. Ellis, J. A. Nathanson, J. Rabe, and K. J. Sweadner Carbachol and Nitric Oxide Inhibition of Na,K-ATPase Activity in Bovine Ciliary Processes Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2625 - 2631. [Abstract] [Full Text] [PDF]

				J. C. Fleischhauer, J.-L. Bény, J. Flammer, and I. O. Haefliger NO/cGMP Pathway Activation and Membrane Potential Depolarization in Pig Ciliary Epithelium Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1759 - 1763. [Abstract] [Full Text]

				T. Matsuo Basal nitric oxide production is enhanced by hydraulic pressure in cultured human trabecular cells Br. J. Ophthalmol., June 1, 2000; 84(6): 631 - 635. [Abstract] [Full Text]

				M. Kanno, M. Araie, H. Koibuchi, and K. Masuda Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans Br. J. Ophthalmol., March 1, 2000; 84(3): 293 - 299. [Abstract] [Full Text]